These Healthcare stocks are trading higher:
-Novan Inc (NOVN) stock is trading at $16.53, an increase of $7.49, or 89.27%, on high volume. Novan Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $30.33.
-Vaxart Inc (VXRT) stock is trading at $8.96, a rise of $1.78, or 27.62%, on low volume. Vaxart Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $13.33.
-Progenity Inc (PROG) stock is trading at $2.92, a gain of $0.43, or 23.29%, on average volume. Progenity Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $4.75.
-Aptinyx Inc (APTX) stock is trading at $3.88, a rise of $0.67, or 22.74%, on high volume. Aptinyx Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $9.71.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Orphazyme A S ADR (ORPH) stock is trading at $11.70, a drop of $9.3, or 41.71%, on high volume. Orphazyme A/S ADR gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.00.
-Curis, Inc. (CRIS) stock is trading at $8.49, a decline of $4.19, or 32.37%, on moderate volume. Curis Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $17.75.
-Aptose Biosciences Inc (APTO) stock is trading at $3.86, a loss of $1.68, or 30.61%, on high volume. Aptose Bioscns gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.40.
-Heat Biologics Inc (HTBX) stock is trading at $7.58, a decline of $2.02, or 21.15%, on moderate volume. Heat Biologics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $23.20.
